Our focus on finding a way to help every person with PAH has led us to explore various technologies and products. Lung perfusion is a major focus of our work as we develop ways to preserve and assess lungs for transplant.

XenoLung seeks to increase access to and improve outcomes after lung transplantation for people with PAH and other fatal lung diseases. The promise of lung transplantation as an effective therapy for PAH and other fatal lung diseases is widely accepted.